Vivo Opportunity LLC insider trades

Open-market stock purchases and sales by Vivo Opportunity LLC, 10% Owner at InMed Pharmaceuticals Inc, from SEC Form 4 filings since Jan 29, 2020.

Track record: 0% of 18 scored buys are up 5% or more since purchase, averaging -13%.

Recent trades

DateStockTradeValue
Jun 8, 2026INM InMed Pharmaceuticals IncBought$44.9K
Jun 8, 2026INM InMed Pharmaceuticals IncBought$4.5K
Jun 5, 2026INM InMed Pharmaceuticals IncBought$78.4K
Jun 5, 2026INM InMed Pharmaceuticals IncBought$7.9K
Jun 4, 2026INM InMed Pharmaceuticals IncBought$9.6K
Jun 4, 2026INM InMed Pharmaceuticals IncBought$970
Jun 3, 2026INM InMed Pharmaceuticals IncBought$11K
Jun 3, 2026INM InMed Pharmaceuticals IncBought$1.1K
Jun 2, 2026INM InMed Pharmaceuticals IncBought$31.5K
Jun 2, 2026INM InMed Pharmaceuticals IncBought$3.2K
Jun 1, 2026INM InMed Pharmaceuticals IncBought$23K
Jun 1, 2026INM InMed Pharmaceuticals IncBought$2.3K
May 29, 2026INM InMed Pharmaceuticals IncBought$25.4K
May 29, 2026INM InMed Pharmaceuticals IncBought$2.6K
May 21, 2026INM InMed Pharmaceuticals IncBought$52.2K
May 21, 2026INM InMed Pharmaceuticals IncBought$5.3K
May 20, 2026INM InMed Pharmaceuticals IncBought$79.6K
May 20, 2026INM InMed Pharmaceuticals IncBought$8K

Companies traded

  • INM InMed Pharmaceuticals Inc: 18 buys, last Jun 8, 2026
  • SLNO Soleno Therapeutics Inc: 8 sales, last Mar 28, 2025
  • TERN Terns Pharmaceuticals, Inc: 5 buys, 9 sales, last Apr 3, 2024
  • SRRA Sierra Oncology, Inc: 1 buy, last Jul 1, 2022

Get free alerts when Vivo Opportunity LLC files a new trade →